Storage and handling
Flammable - keep away from fire or flame
Flammable - keep away from fire or flame
Isopropyl Alcohol, 70% v/v
Use: For preparation of the skin befoire injection.
Warnings: For external use only.
Flammable - keep away from fire or flame
Do not use: with electrocautery, in the eyes.
Stop use if irritation and redness develop.
If condition persists for more than 72 hours,
consult your doctor.
Keep out of reach of children. If swallowed,
get medical help or contact a Poison Control
Center right away.
Directions: Wipe injection site vigorously and
Other information: Store at room temperature
15
- 30
degree Celsius (59
- 86
Farenheit)
Inactive Ingredient: Purified water
LOT/EXP: Made in CHINA
20140301
Benzocaine, 6% w/v.
SD alcohol, 60% w/v
Use: for the temporary relief of pain and itching associated with minor burn, scrapes, and insect bites.
Warnings: For external use only.
Avoid contact with eyes. If this happens,
rinse thoroughly with water.
Keep out of reach of children. If swallowed, get medical help
or contact a Poison Control Center right away.
Flammable - keep away from fire or flame.
Do not use: In eyes, on broken skin, deep
puncture wounds. If unusual redness, swelling,
irritation or other symptoms occur, consult a
physician immediately.
Made in CHINA
LOT/EXP:
Inactive Ingredient: Purified Water
Aspirin 81 mg (NSAID *)
Uses
Temporary relief of minor aches, pains and headaches
to reduce fever associated with colds, sore throats, teething
Warnings
Reye's Syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome.
Stomach bleeding warning: This product contains a non-steroidal anti-inflammatory drug (NSAID), which may cause stomach bleeding. The chance is higher if the user; has had stomach ulcers or bleeding problems
takes a blood thinning (anticoagulant) or steroid drug
takes other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others)
takes more or for a longer time than directed
is age 60 or older
has 3 or more alcoholic drinks every while using this product.
Do not use
if you are allergic to aspirin or any other pain relievers/fever reducers
for more than 10 days for pain unless directed by a doctor
for more than 3 days for fever unless directed by a doctor
for at least 7 days after a tonsillectomy or oral surgery
Ask a doctor before use if you have;
asthma
stomach problems (such as heartburn, upset stomach, or stomach pain) that persist or recur, ulcers or bleeding problems
a child experiencing arthritis pain
if you are;
allergic to aspirin
taking prescription drug for anticoagulation (thinning of blood), diabetes, gout or arthritis
Stop use and ask a doctor if;
an allergic reaction occurs, Seek medical help right away
pain or fever persists
new or unexpected symptoms occur
redness or swelling is present
ringing in ears or loss of hearing occurs
If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use aspirin during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in unborn child or complications during delivery.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center immediately.
Directions Do not use more than directed
Adults and Children (12 years and older): Chew 4 to 8 tablets with water every 4 hours, Do not exceed 48 tablets in 24 hours unless directed by a doctor.
Children Under 12 years: Consult a doctor.
Store at room temperature
tamper evident sealed packets
do not use any opened or torn packets
Inactive ingredients flavor, FD and C yellow No. 6, saccharin, sodium, silicon dioxide, starch, stearic acid, sucrose
MADE IN USA
Distributed by GENUINE FIRST AID
600 Cleveland Str Suite 400, Clearwater, FL 33755
Antiseptic
Antiseptic
Analgesic/Antipyretic
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 318272 | aspirin 81 MG Chewable Tablet | PSN | 17 |
| 1046313 | benzocaine 6 % / ethanol 60 % Medicated Pad | PSN | 17 |
| 797544 | isopropyl alcohol 70 % Medicated Pad | PSN | 17 |
| 318272 | aspirin 81 MG Chewable Tablet | SCD | 17 |
| 1046313 | benzocaine 60 MG/ML / ethanol 0.6 ML/ML Medicated Pad | SCD | 17 |
| 797544 | isopropyl alcohol 0.7 ML/ML Medicated Pad | SCD | 17 |
| 318272 | ASA 81 MG Chewable Tablet | SY | 17 |
| 1046313 | benzocaine 6 % / ethanol 60 % Topical Swab | SY | 17 |
| 797544 | isopropyl alcohol 70 % Medicated Pad | SY | 17 |
| 797544 | isopropyl alcohol 70 % Topical Cloth | SY | 17 |
| 797544 | isopropyl alcohol 70 % Topical Swab | SY | 17 |
| Class | Version | Type | Effective |
|---|---|---|---|
| ASPIRIN Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20191108 |
| BENZOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 52124-0114-1 | 2023-01-30 | C162847 | 48780-1 | 9d75b9d0-5002-f424-e053-dadaa90a57ce | Kit5 Protection |
| 52124-0114-1 | 2021-02-04 | C162847 | 48780-1 | 9d75b9d0-5002-f424-e053-dadaa90a57ce | Kit5 Protection |
| 52124-0114-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-5002-f424-e053-dadaa90a57ce | Kit5 Protection |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52124-0114-1 | Protection | 1 in 1 KIT | KIT | 1 | 17 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 52124-0114 | PROTECTION (ISOPROPYL ALCOHOL, BENZOCAINE, ALCOHOL, ASPIRIN) KIT [GENUINE FIRST AID LLC] | 17 | Legacy NDC, 1 package rows | 20210205_1b6b097e-00cf-4537-8c6f-257fa1f95bfa.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ALCOHOL | ACTIVE INGREDIENT | 3K9958V90M | 10 | |
| ASPIRIN | ACTIVE INGREDIENT | R16CO5Y76E | 10 | |
| BENZOCAINE | ACTIVE INGREDIENT | U3RSY48JW5 | 10 | |
| ISOPROPYL ALCOHOL | ACTIVE INGREDIENT | ND2M416302 | 10 | |
| ALCOHOL | ACTIVE MOIETY | 3K9958V90M | 10 | |
| ASPIRIN | ACTIVE MOIETY | R16CO5Y76E | 10 | |
| BENZOCAINE | ACTIVE MOIETY | U3RSY48JW5 | 10 | |
| ISOPROPYL ALCOHOL | ACTIVE MOIETY | ND2M416302 | 10 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | 10 | |
| SACCHARIN | INACTIVE INGREDIENT | FST467XS7D | 10 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 10 | |
| SODIUM CATION | INACTIVE INGREDIENT | LYR4M0NH37 | 10 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | 10 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 10 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 10 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 10 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 52124-0114 | 52124-0114-1 |
| 52124-0002 | |
| 52124-0008 | |
| 52124-0012 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| ISOPROPYL ALCOHOL | ND2M416302 | ACTIB |
| WATER | 059QF0KO0R | IACT |
| BENZOCAINE | U3RSY48JW5 | ACTIB |
| ALCOHOL | 3K9958V90M | ACTIB |
| FD&C YELLOW NO. 6 | H77VEI93A8 | IACT |
| SACCHARIN | FST467XS7D | IACT |
| SODIUM CATION | LYR4M0NH37 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| SUCROSE | C151H8M554 | IACT |
| ASPIRIN | R16CO5Y76E | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | EMULSION / TOPICAL | NA | ||
| SACCHARIN | SACCHARIN | FST467XS7D | SYRUP / ORAL | 8 mg | ||
| SACCHARIN | SACCHARIN | FST467XS7D | TABLET, CHEWABLE / ORAL | 0.9 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | SUSPENSION, EXTENDED RELEASE / ORAL | 113 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CAPSULE / ORAL | 90 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 190 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, DELAYED RELEASE / ORAL | 40 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SOLUTION / RECTAL | 35.42 %w/v | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SYRUP / ORAL | 46400 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 19 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / SUBLINGUAL | 9 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION, EXTENDED RELEASE / ORAL | 70 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, EXTENDED RELEASE / TRANSDERMAL | 49 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 308 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, LIQUID FILLED / ORAL | 106 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | POWDER, FOR SUSPENSION / ORAL | 1203 mg/5ml | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | GEL / TOPICAL | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SOAP / TOPICAL | 6 %w/w | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | SOLUTION / ORAL | 75.3 mg/15ml | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / SUBLINGUAL | 10 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SOLUTION / ORAL | 1.8 mg/120ml | ||
| SUCROSE | SUCROSE | C151H8M554 | TROCHE / BUCCAL | NA | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | CAPSULE, LIQUID FILLED / ORAL | 1 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 2000 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / BUCCAL | 3 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | ELIXIR / ORAL | 5.4 mg/5ml | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | LOZENGE / ORAL | 120 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | CAPSULE, EXTENDED RELEASE / ORAL | 194 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | INSERT / VAGINAL | 147 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SYSTEM / TRANSDERMAL | 35 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / VAGINAL | 4 %w/w | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET, EXTENDED RELEASE / ORAL | 8 mg | ||
| SACCHARIN | SACCHARIN | FST467XS7D | POWDER, FOR SOLUTION / ORAL | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | PELLET / SUBCUTANEOUS | 0.97 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | ELIXIR / ORAL | 18000 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, EXTENDED RELEASE / ORAL | 184 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / NASAL | 20 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED PELLETS / ORAL | 69 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SOLUTION / ORAL | 336 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | IMPLANT / SUBCUTANEOUS | 1.04 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | SYRUP / ORAL | 4 mg/5ml | ||
| SACCHARIN | SACCHARIN | FST467XS7D | GRANULE, FOR SOLUTION / ORAL | 16 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | DROPS / ORAL | NA | ||
| SACCHARIN | SACCHARIN | FST467XS7D | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 0.05 %w/w | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, CHEWABLE / ORAL | 180 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, FILM COATED / ORAL | 2000 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / ORAL | 300 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE / ORAL | NA | ||
| SACCHARIN | SACCHARIN | FST467XS7D | PASTE, DENTIFRICE / DENTAL | 0.23 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ba4c1bfb-29c6-0c17-e053-2995a90a7d70 | 1b6b097e-00cf-4537-8c6f-257fa1f95bfa | 2021-02-01 | Warnings | ba4c1bfb-29c6-0c17-e053-2995a90a7d70 1b6b097e-00cf-4537-8c6f-257fa1f95bfa |
Adverse event summaries are temporarily unavailable. Other product information remains available.